Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. (ACHV) Revenue
Annual & quarterly revenue history · segment & region breakdown
ACHV · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAchieve Life Sciences, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | -$0.01B | -100.00% |
| 2016-12-31 | $0.01B | -$0.01B | -72.13% |
Compare revenue vs peers
BiotechnologyCompare ACHV revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Achieve Life Sciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Achieve Life Sciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Achieve Life Sciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ACHV revenue · 4 questionsACHV's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Achieve Life Sciences, Inc. SEC filings · GAAP · Achieve Life Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026